• 1
    Lucassen A. Ethical implications of new genetic technologies. Dev Med Child Neurol 2012; 54: 196.
  • 2
    Manning M, Hudgins L; Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010; 12: 7425.
  • 3
    Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 74964.
  • 4
    Reiff M, Bernhardt BA, Mulchandani S, et al. “What does it mean?”: uncertainties in understanding results of chromosomal microarray testing. Genet Med 2012; 14: 2508.
  • 5
    Reiff M, Bernhardt BA, Mulchandani S, et al. Physicians’ perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clin Genet 2013; 83: 2330.
  • 6
    Feero WG, Green ED. Genomics education for health care professionals in the 21st century. JAMA 2011; 306: 98990.
  • 7
    Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST; Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011; 13: 6805.
  • 8
    Pichert G, Mohammed SN, Ahn JW, Ogilvie CM, Izatt L. Unexpected findings in cancer predisposition genes detected by array comparative genomic hybridisation: what are the issues? J Med Genet 2011; 48: 5359.
  • 9
    Schaaf CP, Scott DA, Wiszniewska J, Beaudet AL. Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet 2011; 377: 5556.
  • 10
    Coulter ME, Miller DT, Harris DJ, et al. Chromosomal microarray testing influences medical management. Genet Med 2011; 13: 7706.